New diabetes drug adversely affects 3 for first time in Indi
Sonali Mehta
New diabetes drug adversely affects 3 for first time in India
For the first time ever, adverse drug reactions associated with the use of a new class of anti-diabetes medicine (SGLT-2 inhibitors) have been reported from India. Three patients who had been prescribed the new class of anti-diabetes therapy have reported certain complications called ketonemia, where the body produces high levels of blood acids (ketones) that may also require hospitalisation...
http://health.economictimes.indiatimes.com/news/diagnostics/new-diabetes-drug-adversely-affects-3-for-first-time-in-india/52893874
Like
Comment
Share